Davion Healthcare Plc filed a Form 6-K with the SEC on November 9, 2026, disclosing that 7,877,590 ordinary shares were registered in the name of Cede & Co. as of November 6, 2026, in response to shareholder enquiries.
Key Highlights
- Share registration balance: 7,877,590 ordinary shares were registered in the name of Cede & Co. as of November 6, 2026, according to records provided by transfer agent Vstock Transfer LLC.
- Nominee structure: Cede & Co. holds these shares as registered nominee for DTC participants on behalf of underlying beneficial owners.
- Filing trigger: The disclosure was made in response to shareholder enquiries, the filing states.
- Scope limitation: The company stated the figure "does not constitute a measure of shares available for sale or lending, short interest, or failures to deliver."
- Signed by: Glenn Williams, Chief Executive Officer, dated November 9, 2026.
Davion Healthcare Clarifies Cede & Co. Registration Balance for Shareholders
Davion Healthcare Plc, a foreign private issuer incorporated in Ireland and listed on NASDAQ:DAVI, submitted a Form 6-K under Item 7.01 Regulation FD Disclosure. According to the filing, the company confirmed that, as of November 6, 2026, Vstock Transfer LLC, its transfer agent, recorded 7,877,590 ordinary shares registered in the name of Cede & Co., the nominee of The Depository Trust Company (DTC).
The filing explains that Cede & Co. functions as the registered nominee for DTC participants, holding shares on behalf of underlying beneficial owners. The company emphasized the limited scope of this figure, stating verbatim that it "does not constitute a measure of shares available for sale or lending, short interest, or failures to deliver." The disclosure was made specifically in response to shareholder enquiries, the registrant noted.
The report was filed for the month of November 2026 under Commission File Number 001-42981. The company's principal executive office is located at Unit A, West Cork Business Park, Clonakilty, County Cork, Ireland. The filing was signed by Chief Executive Officer Glenn Williams on November 9, 2026.
What Was Disclosed
Davion Healthcare Plc disclosed that 7,877,590 ordinary shares were registered to Cede & Co. as of November 6, 2026, per its transfer agent's records. The company clarified the figure reflects only a registration balance and not any measure of trading activity or short interest.



Please wait processing your request...